email@example.com (Lydia Ramsey)Business InsiderMay 11, 2020, 4:14 PM CDT
AP Photo/David J. Phillip
- Two studies published recently medical journals found that the anti-malaria medication hydroxychloroquine failed to help hospitalized coronavirus patients.
- The studies, both observational, looked at the outcomes of more than 2,000 hospitalized coronavirus patients in New York collectively.
- Hydroxychloroquine got attention early on in the pandemic as a potential treatment for COVID-19, the disease caused by the novel coronavirus. It has not been approved by the FDA for the treatment of COVID-19.